Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 8.30
+0.30 (3.75%)
Jul 16, 2025, 5:15 PM CET
Fluicell AB Revenue
Fluicell AB had revenue of 2.65M SEK in the quarter ending March 31, 2025, with 728.75% growth. This brings the company's revenue in the last twelve months to 7.68M, up 312.29% year-over-year. In the year 2024, Fluicell AB had annual revenue of 5.35M with 60.25% growth.
Revenue (ttm)
7.68M
Revenue Growth
+312.29%
P/S Ratio
1.43
Revenue / Employee
698.27K
Employees
12
Market Cap
10.99M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| Vimian Group AB | 4.24B |
| AddLife AB | 10.42B |